Bifogade filer
PDF
Kurs
-1,58%
Likviditet
1,52 MNOK
Kalender
| Est. tid* | ||
| 2025-08-28 | 18:50 | Kvartalsrapport 2025-Q2 |
| 2025-06-06 | N/A | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2025-06-05 | N/A | Årsstämma |
| 2025-04-10 | - | Bokslutskommuniké 2024 |
| 2024-08-29 | - | Kvartalsrapport 2024-Q2 |
| 2024-06-19 | - | Årsstämma |
| 2024-06-06 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2024-04-25 | - | Bokslutskommuniké 2023 |
| 2023-10-04 | - | Split CRNA 30:1 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-22 | - | Årsstämma |
| 2023-04-21 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2023-03-09 | - | Extra Bolagsstämma 2023 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-11-03 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-18 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-20 | - | Årsstämma |
| 2022-04-07 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-25 | - | Extra Bolagsstämma 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-18 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-18 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2021-03-17 | - | Årsstämma |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-05 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-30 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2020-04-29 | - | Årsstämma |
| 2020-03-11 | - | Bokslutskommuniké 2019 |
| 2019-11-07 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-09 | - | Kvartalsrapport 2019-Q1 |
| 2019-04-10 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2019-04-09 | - | Årsstämma |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-11-01 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-23 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-03 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-12 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2018-04-11 | - | Årsstämma |
| 2018-02-15 | - | Bokslutskommuniké 2017 |
| 2017-11-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-04-25 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-05 | - | Årsstämma |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-12 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-14 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2016-04-13 | - | Årsstämma |
| 2015-06-23 | - | X-dag ordinarie utdelning CRNA 0.00 NOK |
| 2015-06-22 | - | Årsstämma |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Oslo, Norway, 1 March 2023: Reference is made to Targovax ASA's ("Targovax" or the "Company") stock exchange announcement on 16 February 2023 where the Company called for an extraordinary general meeting (EGM) to be held at the Company's offices at Lysaker on 9 March 2023 at 10:00 CET for the purpose of approving the investment agreement for up to NOK 300m in convertible bonds with Atlas Special Opportunities, LLC ("Atlas").
Important and relevant parts of the Investment and Subscription Agreement with Atlas has been published on the Company's website: https://www.targovax.com/en/extraordinary-general-meeting-2023/ and is also attached to this notice.
A webcast presentation with a Q&A regarding the Atlas convertible bond facility was held 28 February 2023. A recording of the presentation and the presentation material is available on our web site on the following link: https://www.targovax.com/en/presentations/.
Attachment: Atlas investment Agreement Public Terms (https://mb.cision.com/Public/17093/3725461/9751250818e84b14.pdf)
***
Erik Digman Wiklund, CEO
Phone: +47 413 33 536
Email: erik.wiklund@targovax.com
Renate Birkeli, Investor Relations
Phone: +47 922 61 624
Email: renate.birkeli@targovax.com
Media enquires:
Andreas Tinglum - Corporate Communications (Norway)
Phone: +47 9300 1773
Email: andreas.tinglum@corpcom.no